Work

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

Year: 2013

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2013.04.050

Authors: Sharon E. Frey, Patricia L. Winokur, Robert A. Salata, Samer S. El-Kamary, Christine B. Turley, Emmanuel B. Walter, Christine Mhorag Hay, Frances K. Newman, Heather R. Hill, Ying Zhang, Paul Chaplin, Magdalena Tary-Lehmann, Robert B. Belshe

Institutions: Saint Louis University, University of Iowa, Iowa City VA Medical Center, University Hospitals Cleveland Medical Center, Case Western Reserve University, University of Maryland, Baltimore, The University of Texas Medical Branch at Galveston, Duke University, Duke Medical Center, University of Rochester, Emmes (United States), Bavarian Nordic (Germany)

Language: English

Topic: Poxvirus research and outbreaks

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Center for Research Resources

Awards: G1072627501, G1087496591, IN VITRO AND ANIMAL MODELS FOR EMERGING DISEASES AND BIODEFENSE, G2342806175, G2948059169, Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine, Vaccine and Treatment Evaluation Units (VTEUs) , Immunomodulation of Sophorolipids in Sepsis, G4965763455, University of Iowa Clinical and Translational Science Program (UL1), G574345120, G6358276902, G6528419944, G689028762, G7204274223, Duke CTSI, G8475336653, G8812641489, Vaccine and Treatment Evaluation Unit

OpenAlex ID: W2001421749

FWCI: 1.833

Cites: 20

Cited by: 76

Related to: 10